(1) The UK-headquartered bioelectronics company has set its sights on the US healthtech market following a series of new investors, new product developments and a 156% sales increase. Leading bioelectronic innovator NuroKor BioElectronics has announced plans to ramp up its US expansion, following 12 months of rapid growth during which the company's half-year sales rose by 156%. NuroKor, which pioneers the development of wearable technology that uses bioelectric nerve, muscle and microcurrent stimulation to help manage pain and optimise physical performance, has today announced a major new partnership with Medi-Launch Partners, as well as the onboarding of Florida-based U.S investors. Medi-Launch Partners, the New York and Southern California-based enterprise, specialises in the launch and distribution of pioneering medical devices and will be working with NuroKor to optimise the commercial success of NuroKor's mibody and newly developed mediliev Rx devices across the US through over the counter and prescription avenues to support with chronic pain management and recovery.